CTRI/2020/02/023139
Not yet recruiting
未知
Study of mtDNA mutations in urothelial carcinoma of bladder
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C679- Malignant neoplasm of bladder, unspecified
- Sponsor
- KEM Hospital
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •In summary: All Carcinoma bladder patients undergoing Transurethral resection / Radical cystectomy at Dept. of Urology, KEMH
Exclusion Criteria
- •All patient undergoing TURBT whose biopsy report turns out to be non malignant.
- •Patients who donâ??t give consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Exploring DNA methylation biomarkers associated with bladder cancer in patients with neurogenic bladderISRCTN37551129Aristotle University of Thessaloniki70
Completed
Not Applicable
Development of urothelial cancer-Specific mRNA and miRNA Assay in Human Urinary Exosomes and MicrovesiclesBladder CancerJPRN-UMIN000030054Hokkaido University Graduate School of Medicine600
Not yet recruiting
Not Applicable
Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With HematuriaHematuriaUrothelial CarcinomaBladder CancerUreter CancerRenal Pelvis CancerNCT06469229Changhai Hospital1,200
Recruiting
Not Applicable
Analysis of gene alterations in NUT midline carcinomaMalignant thoracic tumorsJPRN-UMIN000043147Asahikawa Medical University100
Active, not recruiting
Phase 2
Assessing the use of tailored treatments based on combinations of genes that are active in a tumour, and the impact on outcomes for bladder cancer.ISRCTN17378733Sheffield Teaching Hospitals NHS Foundation Trust320